These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2945270

  • 1. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors.
    Sharp HK, McIlveen LP, Schuman NJ.
    Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270
    [No Abstract] [Full Text] [Related]

  • 2. Maintenance of hemostasis during exodontia in two hemophiliacs with factor VIII inhibitors.
    Zech R, Strother SV.
    J Oral Maxillofac Surg; 1983 Jan; 41(1):53-6. PubMed ID: 6217303
    [Abstract] [Full Text] [Related]

  • 3. Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acid.
    Agrawal BL, Zelkowitz L, Hletko P.
    J Pediatr; 1981 Jun; 98(6):931-3. PubMed ID: 7229796
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
    Iizuka A, Kuwashima M, Nagao T.
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
    Zwahlen H, Beck EA.
    Acta Haematol; 1980 Sep; 64(1):12-7. PubMed ID: 6774572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
    Tourbaf KD, Dunlap BE, Ambrus JL, Rodman DJ, Atwal AJ.
    J Med; 1982 Sep; 13(5-6):399-410. PubMed ID: 6820380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of dental extractions in two hemophilia A patients with factor VIII inhibitor.
    Shurafa M, MacIntosh RB.
    J Oral Maxillofac Surg; 1987 Aug; 45(8):698-701. PubMed ID: 2956401
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [HEMORRHAGIC DISORDERS IN HEMOPHILIA, WITH A SPECIAL REFERENCE TO FIBRINOLYSIS].
    KATSUMI O.
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():788-97. PubMed ID: 14154696
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors.
    Hilgartner MW, Knatterud GL.
    Blood; 1983 Jan; 61(1):36-40. PubMed ID: 6401216
    [Abstract] [Full Text] [Related]

  • 19. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR.
    N Engl J Med; 1981 Sep 24; 305(13):757-8. PubMed ID: 6790992
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of hemophilia complicated by inhibitors.
    Scand J Haematol Suppl; 1980 Sep 24; 35():135-64. PubMed ID: 6770458
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.